Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07127965 · ClinicalTrials.gov registry record · NA

Exercise Adherence and Cognitive Decline: Phase 2

A NA study of Cognitive Decline, sponsored by University of Colorado, Boulder.

Recruiting
Registry status
NA
Development phase
226
Enrollment target
2
Study locations

NCT07127965: Recruiting NA study of Cognitive Decline, sponsored by University of Colorado, Boulder.

NCT07127965 is a NA study of Cognitive Decline that is actively recruiting participants, run by University of Colorado, Boulder. The registered enrollment target is 226 participants, below the 1,146-participant average among 61 other Cognitive Decline trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07127965, a NA study of Cognitive Decline, is actively recruiting participants, sponsored by University of Colorado, Boulder.

RECRUITING
Registry status
NA
Development phase
226 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to conduct a test of a goals-based program to help people exercise more. This program was designed for individuals aged 45-65 from the Black community. Low levels of physical activity are related to health problems such as heart disease, diabetes, and cognitive decline. People of color are more negatively impacted by these conditions and have also historically been underrepresented by research seeking to increase physical activity. The investigators have developed this goals-based exercise promotion program with the help of a Black-led community-based organization (The Gyedi Project) and a Community Advisory Board made up of stakeholders in the Black community.

Primary Outcome

Blood pressure (systolic and diastolic) of all participants is collected before the intervention

Conditions Studied

Interventions

  • BEHAVIORAL Goal Setting and Exercise Intensity Intervention

Study Locations (2)

Colorado

  • Recreation Centers in the Denver Metro Area - Aurora
  • University of Colorado at Boulder - Boulder

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2025-11-05
Est. Completion 2028-08-31
Phase NA
University of Colorado, Boulder

69 total trials

What NCT07127965 shows while recruiting

NCT07127965 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,146-participant average among 61 other Cognitive Decline trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Goal Setting and Exercise Intensity Intervention is the first listed.

NCT07127965 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT07127965 about?

NCT07127965 is a clinical study titled "Exercise Adherence and Cognitive Decline: Phase 2". The purpose of this study is to conduct a test of a goals-based program to help people exercise more. This program was designed for individuals aged 45-65 from the Black community. Low levels of physical activity are related to health problems such as heart disease, diabetes, and cognitive decline. ...

What is the current status of trial NCT07127965?

This trial is currently recruiting. It is a NA study. The enrollment target is 226 participants. The study started on 2025-11-05. Estimated completion is 2028-08-31.

What conditions does trial NCT07127965 study?

This clinical trial studies the following conditions: Cognitive Decline.

What interventions are being tested in trial NCT07127965?

The interventions under investigation include: Goal Setting and Exercise Intensity Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07127965?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07127965 being conducted?

This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Decline

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07127965's enrollment target sits among peer trials

226 23rd of 61 higher than 39 of 61 other Cognitive Decline trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07127965, the US trial registry maintained by the National Library of Medicine. NCT07127965 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.